Clinical Trial Update: A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer [NA]

View source ↗

Summary

Update on a Phase II study of the TheraBionic P1 Device for hormone receptor-positive, HER2-negative breast cancer, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• TheraBionic P1 Device

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: HER2-negative Breast Cancer, Hormone Receptor Positive Tumor | NA | Status: NOT_YET_RECRUITING